Hikma Pharmaceuticals PLC (LON:HIK)
London · Delayed Price · Currency is GBP · Price in GBX 1,343.00
-5.00 (-0.37%)
Apr 16, 2026, 4:54 PM GMT
Hikma Pharmaceuticals Market Cap
Hikma Pharmaceuticals has a market cap or net worth of 2.91 billion as of April 16, 2026. Its market cap has decreased by -31.77% in one year.
Market Cap
2.91B
Enterprise Value
3.93B
Revenue
2.49B
Ranking
n/a
PE Ratio
10.02
Stock Price
1,343.00
Market Cap Chart
Since November 2, 2005, Hikma Pharmaceuticals's market cap has increased from 469.64M to 2.91B, an increase of 520.31%. That is a compound annual growth rate of 9.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 2.90B | -15.44% |
| Dec 31, 2025 | 3.43B | -22.33% |
| Dec 31, 2024 | 4.42B | 11.74% |
| Dec 29, 2023 | 3.96B | 15.72% |
| Dec 30, 2022 | 3.42B | -33.45% |
| Dec 31, 2021 | 5.14B | -11.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Haleon | 31.48B |
| HUTCHMED (China) | 1.89B |
| Allergy Therapeutics | 690.25M |
| Animalcare Group | 170.54M |
| Shield Therapeutics | 99.90M |
| Venture Life Group | 81.62M |
| ECO Animal Health Group | 70.13M |
| Provexis | 24.40M |